Benzodiazepine Dependence and Addiction Treatment in the UK

Assessment should record the exact medicines, source, duration and current pattern; attempts to reduce; withdrawal experiences; alcohol, opioid, gabapentinoid or other sedative use; sleep; anxiety; physical health; and overdose or seizure history.

Bring an up-to-date medication list to a prescriber. Non-prescribed tablets may have uncertain contents, which adds risk and reinforces the need for honest, qualified assessment rather than self-directed dose changes.

Some people need only careful medication review and prescriber-led reduction. Others have loss of control, non-prescribed use, escalating doses, several substances, repeated unsuccessful attempts or a wider addiction pattern that benefits from specialist drug-treatment support.

Residential care may be considered when risks or complexity cannot be managed in the community, but the facility must demonstrate appropriate medical governance, prescribing capability, monitoring, mental-health provision and continuity after discharge. A comfortable setting without the right medical team is not suitable.

Ask who is medically responsible, who prescribes, what professional registrations apply, how the plan is individualised and reviewed, and how seizures, severe symptoms, other sedatives and mental-health deterioration are managed.

Ask what happens after any admission or stabilisation period. Medication continuity, GP or specialist handover, therapy, sleep and anxiety support, family communication and relapse prevention should be explicit before treatment starts.